News • HPV vaccines and pap smear tests

Keys to prevent many cervical cancer cases

Hundreds of thousands of cervical cancer cases per year could be prevented through widespread vaccinations for human papillomavirus (HPV) and annual pap smear tests, says an expert at a top American hospital, Cleveland Clinic, marking Cervical Cancer Awareness Month in January.

portrait of Robert DeBernardo
Dr. Robert DeBernardo is Section Head of Gynecologic Oncology and Vice Chair Subspecialty Care for Women’s Health at Cleveland Clinic

Dr. Robert DeBernardo, Section Head of Gynecologic Oncology and Vice Chair Subspecialty Care for Women’s Health at Cleveland Clinic, said: “Cervical cancer is one of the leading causes of cancer-related death for young women, but is also entirely preventable between widespread HPV vaccinations and early and frequent annual screenings with pap smear tests. HPV vaccines can protect both men and women from HPV infections; women from cervical cancer; and men from many types of head and neck cancer, too.”

Cancer of the cervix is the fourth-most common cancer among women worldwide, according to the World Health Organization. About 570,000 women are diagnosed with cervical cancer every year, and 311,000 die from the disease annually. The United States’ National Cancer Institute reports recent research found widespread HPV vaccinations reduced cervical cancer by 90 percent. It is estimated that 99 percent of cases of cervical cancer are caused by human papillomaviruses (HPV), frequently acquired through sexual contact, although only specific types of HPV are a risk factor for cervical cancer. 

Recommended article

Photo

News • DIY testing

Self-sampling identifies twice as many women at risk of cervical cancer

Using self-sampling followed by HPV testing, more than twice as many women at risk of developing cervical cancer could be identified and offered preventive treatment. This is shown by researchers at Uppsala University in the first randomised study in the world comparing two ways of identifying cervical cancer, published in the British Journal of Cancer.

The good news is that cervical cancer is very treatable, especially if it’s caught early on

Robert DeBernardo

Dr. DeBernardo recommends that women should see a gynecologist annually from the age of 21 onwards and take pap smear tests when recommended by their gynecologist. Pap smear tests are simple tests involving swabbing from the cervix to collect cells, which are then analyzed for the presence of high-risk HPV types in cells and pre-cancer changes in the cervical cells. “Cervical cancer can develop slowly over many years, with pre-cancerous cells becoming cancerous, which is why screening is vital,” added Dr. DeBernardo. “The good news is that cervical cancer is very treatable, especially if it’s caught early on. In developing countries that may lack the testing infrastructure, there is strong potential for low-cost take-home pap smear tests. Women can take the tests at home, and if they test positive, can undergo follow-up medical exams.”

In the initial stages, cervical cancer can be treated by surgical removal of the cancerous tissue or radiation therapy. Cleveland Clinic cites a five-year survival rate of more than 90 percent if it is caught in the earliest stage. Later-stage treatment options can include surgery, radiation, and chemotherapy.

Supporting treatment innovations, Cleveland Clinic has trialed new medical devices to treat pre-cancer lesions, including a non-gas cryotherapy machine to freeze the lesions, and one that uses heat, rather than cold, to remove the lesions. These devices can be especially useful in developing countries with limited access to hospital facilities and to the cryogenic gas to freeze lesions.


Source: Cleveland Clinic Foundation

05.01.2021

Read all latest stories

Related articles

Photo

Article • Early detection approach

Multi-cancer blood tests could shake up screening

New tests can identify over 50 types of cancer and boost detection of traditionally elusive cancers from tumour DNA in blood, researchers showed at the ESMO congress in September. These multi-cancer…

Photo

Video • Digital patient support tool

Ovarian cancer: "Olivia" to provide information and support

Patients affected by ovarian cancer can turn to "Olivia": The interactive digital resource provides information about diagnostics, treatment and life with ovarian cancer.

Photo

Article • Prediction for breast, ovarian, cervical, and endometrial carcinoma

New test detects four women’s cancers from cervical screening samples

What if a test analysing cervical cells from a gynaecological swab could be used to detect four different female cancers at an early stage and also predict cancer risk over a healthy woman's…

Related products

Beckman Coulter – Diazyme Human Kappa & Lambda FLC assays

Clinical Chemistry

Beckman Coulter – Diazyme Human Kappa & Lambda FLC assays

Beckman Coulter Diagnostics
Canon – Alphenix 4D CT

Multi-Modality Suites

Canon – Alphenix 4D CT

Canon Medical Systems Europe B.V.
Canon - Aquilion Exceed LB

Oncology CT

Canon - Aquilion Exceed LB

Canon Medical Systems Europe B.V.
Canon – Aquilion LB

Oncology CT

Canon – Aquilion LB

Canon Medical Systems Europe B.V.
Canon – Vitrea Advanced Visualization

Reading

Canon – Vitrea Advanced Visualization

Canon Medical Systems Europe B.V.
Subscribe to Newsletter